NCT02363400 2025-08-19A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNANational Health Research Institutes, TaiwanPhase 3 Terminated10 enrolled
NCT01720563 2025-06-04A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent ChemoradiotherapyPhytoHealth CorporationPhase 2 Terminated17 enrolled